课题基金 / 基金详情

Designing modulators of PI 3-kinase delta (PI3Kdelta) for the treatment of haematological malignancies

Designing modulators of PI 3-kinase delta (PI3Kdelta) for the treatment of haematological malignancies
设计用于治疗血液恶性肿瘤的 PI 3 激酶 δ (PI3Kdelta) 调节剂
批准号:
MC_PC_MR/S02607X/1
负责人:
Bart Vanhaesebroeck
金额:
$7.55万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2019
资助国家:
英国
项目状态:
已结题
起止时间:
2019 至 --

项目摘要

项目成果

Bart Vanhaesebroeck的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This proposal is aimed at creating medicines that can control a protein called PI3Kdelta, for use in the treatment of blood cancers such as acute lymphoblastic leukaemia (ALL). It is based on clinical insight provided by our team, who are treating patients with this disease and recognise the need for improved therapies. We discovered PI3Kdelta and have long-term expertise on this molecule. We believe we have found news ways to modulate PI3Kdelta to treat leukaemia, and would now like to turn these concepts into a medicine, with the help of AstraZeneca.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Integration of lipid and protein kinase signalling in primary cilia biology
  • 批准号:
    BB/W007460/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $60.23万
  • 财政年份:
    2022
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
Isoforms of PI 3-kinase as novel regulators of dsRNA-sensing and inflammation
  • 批准号:
    BB/R017972/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $56.47万
  • 财政年份:
    2018
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
Validation of the Vps34 PI 3-kinase as a new potential drug target in insulin sensitization
  • 批准号:
    BB/M013278/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $15.7万
  • 财政年份:
    2016
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
Revised Milestone 1 for Grant Reference BB/M013278/1
  • 批准号:
    BB/N013522/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $5.05万
  • 财政年份:
    2015
  • 负责人:
    Bart Vanhaesebroeck
  • 依托单位:
海外基金